Filter Results
:
(502)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
- May 1992 (Revised February 1996)
- Teaching Note
Nucleon, Inc., Teaching Note
By: Gary P. Pisano
Teaching Note for (9-692-041).
View Details
Keywords:
Biotechnology Industry
- October 1994 (Revised November 1994)
- Case
DNA Plant Technology Corporation (DNAP)
By: Ray A. Goldberg and Quintus Travis
Keywords:
Biotechnology Industry
Goldberg, Ray A., and Quintus Travis. "DNA Plant Technology Corporation (DNAP)." Harvard Business School Case 595-044, October 1994. (Revised November 1994.)
- November 1985
- Case
Genetics Institute Enters the Seed Business
By: Ray A. Goldberg and Michael Joseph Kennedy
Goldberg, Ray A., and Michael Joseph Kennedy. "Genetics Institute Enters the Seed Business." Harvard Business School Case 586-077, November 1985.
- November 1978 (Revised February 1990)
- Case
Amicon Corp. (C)
Details the negotiations between Amicon and one potential licensee, Jackson.
View Details
Keywords:
Technology;
Patents;
Negotiation Process;
Negotiation Participants;
Health Care and Treatment;
Biotechnology Industry
Capon, Noel. "Amicon Corp. (C)." Harvard Business School Case 579-095, November 1978. (Revised February 1990.)
- April 1995
- Teaching Note
Genzyme Corporation: A Financing History (TN)
By: Timothy A. Luehrman
Teaching Note for (9-294-005).
View Details
Keywords:
Biotechnology Industry
- March 2024
- Case
Biomanufacturing Decentralization by Stämm
By: Paul A. Gompers, Jenyfeer Martínez Buitrago and Mariana Cal
In Buenos Aires, Argentina, cousins Llamazares and D’Alvia founded Stämm, a startup based on the idea of decentralizing biomanufacturing processes and downsizing biotech facilities. After raising its seed and series A rounds, and while finalizing its series B round in...
View Details
Keywords:
Business Model;
Business Startups;
Entrepreneurship;
Venture Capital;
Selection and Staffing;
Technological Innovation;
Science-Based Business;
Business Strategy;
Commercialization;
Growth and Development Strategy;
Product Launch;
Research and Development;
Biotechnology Industry;
Latin America;
South America;
Argentina;
Buenos Aires
- November 2016 (Revised December 2016)
- Supplement
Anthony Starks at InSiL Therapeutics (B)
By: Vicki Sato and Gary Pisano
This case accompanies the (A) case from Anthony Starks's perspective.
View Details
Keywords:
Biotech;
Management Challenges;
R&D;
R&D Project Management;
Management;
Biotechnology Industry;
California
Sato, Vicki, and Gary Pisano. "Anthony Starks at InSiL Therapeutics (B)." Harvard Business School Supplement 617-030, November 2016. (Revised December 2016.)
- October 2009 (Revised January 2014)
- Teaching Note
Sustainability at Millipore (TN)
Teaching Note for [610012].
View Details
- September 2008 (Revised April 2009)
- Supplement
Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)
By: William W. George
Kevin Sharer, CEO of Amgen, is assessing the challenges he has faced as a major product came under regulatory scrutiny.
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Leadership;
Product Development;
Biotechnology Industry
George, William W. "Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)." Harvard Business School Supplement 409-037, September 2008. (Revised April 2009.)
- 2009
- Working Paper
Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs
By: Pierre Azoulay, Christopher C. Liu and Toby E. Stuart
Actors often match with associates on a small set of dimensions that matter most for the particular relationship at hand. In so doing, they are exposed to unanticipated social influences because counterparts have more interests, attitudes, and preferences than would-be...
View Details
Keywords:
Entrepreneurship;
Patents;
Marketplace Matching;
Mathematical Methods;
Science-Based Business;
Power and Influence;
Social and Collaborative Networks;
Biotechnology Industry
Azoulay, Pierre, Christopher C. Liu, and Toby E. Stuart. "Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs." Harvard Business School Working Paper, No. 09-136, May 2009.
- April 2002
- Teaching Note
Anagene, Inc. TN
By: Robert S. Kaplan
Teaching Note for (9-102-030).
View Details
- October 2001 (Revised March 2002)
- Case
Perlegen Sciences
By: Linda A. Hill and Nicole Tempest
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,...
View Details
Keywords:
Innovation Leadership;
Groups and Teams;
Management Teams;
Problems and Challenges;
Business Startups;
Genetics;
Talent and Talent Management;
Innovation Strategy;
Biotechnology Industry
Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
- August 1985 (Revised May 1986)
- Case
BioTechnica International
By: Ray A. Goldberg
Keywords:
Biotechnology Industry
Goldberg, Ray A. "BioTechnica International." Harvard Business School Case 586-014, August 1985. (Revised May 1986.)
- November 1995 (Revised March 1996)
- Case
Ares-Serono (Abridged)
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Keywords:
Biotechnology Industry
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono (Abridged)." Harvard Business School Case 396-104, November 1995. (Revised March 1996.)
- 17 Mar 2009
- First Look
First Look: March 17, 2009
industry players such as the major oil companies? Should he try raising money from the managers of the sovereign funds in countries such as Singapore, Kuwait, and China? How should the firm work with its strategic partners? Khosla knew...
View Details
Keywords:
Martha Lagace
- 15 Feb 2000
- Research & Ideas
The Right Connections
of IPO Team Ties on Investment Bank Affiliation and IPO Success," which examines how individuals' affiliations can affect the formation of alliances at the firm level. To that end, the researchers pinpointed the biotechnology View Details
Keywords:
by Judith A. Ross
- 22 Nov 2016
- First Look
November 22, 2016
economies, many business enterprises defy traditional industry boundaries. In this study, we evaluate six "big data" approaches to peer firm identifications and show that some, but not all, "wisdom-of-crowd" techniques perform...
View Details
Keywords:
Sean Silverthorne
- 06 Oct 2020
- Blog Post
2+2 Where Are They Now Spotlight: Curtis Wu (MBA 2018)
Can you describe your role?I currently work at Amgen Inc at their global HQ in Southern California. Amgen is the largest independent biotechnology company in the world by revenue and our top medicines include autoimmune drug Enbrel, white...
View Details
- July 1993
- Case
Genzyme Corporation: A Financing History
By: Timothy A. Luehrman and Andrew D. Regan
Genzyme Corp.'s financing history is unusual compared to most biotech companies. This case presents the sequence of financings employed by Genzyme, along with the product--market and corporate-development strategies adopted by Henri Termeer, Genzyme's CEO. As such, the...
View Details
Keywords:
History;
Marketing Strategy;
Financing and Loans;
Business Strategy;
Growth and Development Strategy;
Biotechnology Industry
Luehrman, Timothy A., and Andrew D. Regan. "Genzyme Corporation: A Financing History." Harvard Business School Case 294-005, July 1993.
- July 2023
- Case
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Coming out of the COVID-19 pandemic, Moderna was riding the successes of developing a vaccine in record time and helping stem the tide of the crisis. However, the company had grown at an incredible rate, more than doubled its number of employees, and had to put on hold...
View Details
Keywords:
Health Pandemics;
Selection and Staffing;
Growth Management;
Management Succession;
Retirement;
Biotechnology Industry
Tadikonda, Satish, Shikhar Ghosh, and William Marks. "Moderna: Everything, Everywhere, All at Once." Harvard Business School Case 824-021, July 2023.